Espinoza, Nereyda
Rojas, Jesús
Pollett, Simon
Meza, Rina
Patiño, Lilian
Leiva, Manuel
Camiña, Máximo
Bernal, Manuela
Reynolds, Nathanael D.
Maves, Ryan
Tilley, Drake H.
Kasper, Matthew
Simons, Mark P.
Funding for this research was provided by:
U.S. Department of Defense's Global Emerging Infection Systems
Article History
Received: 2 May 2019
Accepted: 29 June 2020
First Online: 16 July 2020
Ethics approval and consent to participate
: The Institutional Review Board of the U.S. Naval Medical Research Unit 6 in Peru (FWA 00010031) determined that the testing of these bacterial isolates (Protocol No PJT.NMRCD.HURS03) did not constitute human subjects research.Samples were collected from patients seeking medical care at their medical care facilities. Because it was regular medical care, these hospitals did not require informed consents or assents.Then, these hospitals tested the samples in compliance with their medical care responsibilities, and isolated the pathogens. These pathogens were provided to NAMRU 6 investigators. NAMRU 6 investigators had no access to identifiable information on these patients.Our collaborative research study involved receiving pathogens to conduct further testing, and sharing results with our collaborators.
: Not applicable.
: The authors declare that there are no financial, institutional or other relationships that might lead to bias or a conflict of interest.